Cellino Biotech Inc — Form D
Cellino Biotech Inc of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-09. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-08-09
- Form: D
- Accession: 0001785112-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.5M
- Investors: 2
- Date of first sale: 2019-05-28
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-346187
Issuer
- Name: Cellino Biotech Inc
- CIK: 0001785112
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 501 MASSACHUSETTS AVENUE, CAMBRIDGE, MA, 02139
- Phone: 404-368-1420
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Katie Rae | Director | Cambridge, MA |
| Nabiha Saklayen | Director | Cambridge, MA |
| Matthias Wagner | Director | Orono, ME |
| Nabiha Saklayen | Executive Officer | Cambridge, MA |
| Matthias Wagner | Executive Officer | Orono, ME |
Other filings by this issuer (1)
More